7 Biotechs Fighting Rare Diseases With Gene-Editing Tech
As of now, only 5% of so-called rare diseases (orphan diseases) have an FDA-approved treatment available to patients. Rare diseases … Read More
Popular articles
Playing Chess Against Cancer: A Pharmaceutical, Biotechnological, and Clinical Guide to Modern Day Oncologic Treatment Cartography
Meet the Company Using Artificial Intelligence for Designing Targeted Protein Degraders
Latest Insights
The Promise of Next-Generation Proteomics in Revolutionizing Cancer Research and Treatment
Meet the Company Using Artificial Intelligence for Designing Targeted Protein Degraders
7 Biotechs Fighting Rare Diseases With Gene-Editing Tech
Playing Chess Against Cancer: A Pharmaceutical, Biotechnological, and Clinical Guide to Modern Day Oncologic Treatment Cartography
9 Notable AI-powered Biotech Companies Founded in 2021
The Expert's Perspective
Basem Goueli, M.D., Ph.D., MBA
The Insider's Guide to Translational Medicine
An exploration of the future of clinical hematology and oncology through precision medicine, drug development, and artificial intelligence.
Editorial column by Dr. Basem Goueli
